clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00021242 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | Canada | Q16 |
United States of America | Q30 | ||
Switzerland | Q39 | ||
New Zealand | Q664 | ||
Netherlands | Q55 | ||
Australia | Q408 | ||
P582 | end time | 2006-03-01 | |
P131 | located in the administrative territorial entity | Puerto Rico | Q1183 |
P4135 | maximum age | 21 | |
P1050 | medical condition | leukemia | Q29496 |
P1132 | number of participants | 12 | |
P6153 | research site | Vanderbilt University | Q29052 |
McGill University | Q201492 | ||
University of Michigan | Q230492 | ||
Stanford University | Q41506 | ||
Southern Illinois University Edwardsville | Q519349 | ||
Wesley Medical Center | Q7983961 | ||
Wilford Hall Medical Center | Q8001708 | ||
Hurley Medical Center | Q14716149 | ||
IWK Health Centre | Q14875689 | ||
Carolinas Medical Center | Q17514683 | ||
Phoenix Children's Hospital | Q18156816 | ||
Cook Children's Medical Center | Q30254344 | ||
AdventHealth Cancer Institute | Q30280268 | ||
CancerCare Manitoba | Q30282110 | ||
Nemours Children's Clinic | Q30287258 | ||
Children's National Hospital | Q5098193 | ||
Cincinnati Children's Hospital Medical Center | Q5120231 | ||
East Tennessee Children's Hospital | Q5329496 | ||
Long Island Jewish Medical Center | Q6672700 | ||
Maimonides Medical Center | Q6735870 | ||
Atrium Health Navicent The Medical Center | Q6806287 | ||
Newark Beth Israel Medical Center | Q7016630 | ||
Princess Margaret Hospital for Children | Q7244698 | ||
Rhode Island Hospital | Q7320925 | ||
Royal Children's Hospital | Q7373942 | ||
St. Joseph's Hospital and Medical Center | Q7589191 | ||
Starship Children's Health | Q7602413 | ||
University of Mississippi Medical Center | Q7895818 | ||
McMaster University | Q632891 | ||
University of Alberta | Q640694 | ||
Saint Louis University | Q734774 | ||
Washington University in St. Louis | Q777403 | ||
St. Jude Children's Research Hospital | Q1164246 | ||
Indiana University – Purdue University Indianapolis | Q1433199 | ||
Fred Hutchinson Cancer Research Center | Q1452369 | ||
Rush University Medical Center | Q1535116 | ||
Kaiser Permanente | Q1721601 | ||
Memorial Sloan Kettering Cancer Center | Q1808012 | ||
Alberta Children's Hospital | Q2831698 | ||
Children's Hospital of Eastern Ontario | Q2945735 | ||
Centre hospitalier universitaire Sainte-Justine | Q2945760 | ||
New York Medical College | Q4115972 | ||
Children's Hospital of Philadelphia | Q4569202 | ||
Nemours Children's Hospital, Delaware | Q4722906 | ||
Children's Hospital of Michigan | Q5098127 | ||
Children's Hospital of Orange County | Q5098129 | ||
UPMC Children's Hospital of Pittsburgh | Q5098130 | ||
Children's Hospital of The King's Daughters | Q5098131 | ||
P580 | start time | 2002-08-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Phase II Study of Docetaxel (Taxotere) (NSC# 628503, IND# 59,761) in Children With Refractory Leukemias |
Search more.